Found: 5
Select item for more details and to access through your institution.
Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy.
- Published in:
- Health Research Policy & Systems, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12961-024-01154-2
- By:
- Publication type:
- Article
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators.
- Published in:
- Journal of Market Access & Health Policy, 2024, v. 12, n. 1, p. 21, doi. 10.3390/jmahp12010004
- By:
- Publication type:
- Article
The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder preconvention questionnaire.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2217543
- By:
- Publication type:
- Article
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 6, p. 1034, doi. 10.1111/bcp.14279
- By:
- Publication type:
- Article
Overview of the European Medicines Agency's Development of Product‐Specific Bioequivalence Guidelines.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 3, p. 539, doi. 10.1002/cpt.957
- By:
- Publication type:
- Article